Trial Profile
Interaction Between Intravenous Magnesium Sulphate and Neostigmine or Sugammadex for the Reversal of a Rocuronium-induced Neuromuscular Block - A Randomized, Double Blinded, Electrophysiological Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2023
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Magnesium sulfate; Neostigmine; Propofol; Rocuronium bromide
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- Acronyms MagNeoSug
- 17 Apr 2023 Status changed from recruiting to completed.
- 01 Jul 2021 Planned End Date changed from 31 Mar 2020 to 31 Jan 2022.
- 01 Jul 2021 Planned primary completion date changed from 31 Dec 2019 to 31 Dec 2021.